At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
The adhesion of circulating cancer cells to vascular endothelium is a key step in metastasis. Understanding this process has the potential to impact the risk of metastasis in cancer patients. Dr. Haines will explain the benefits of using BioFlux to study circulating tumor cell adhesion under physiological flow and review the recent studies in this area.